| RS2101947647 |
CTSK
|
Health Risk |
Likely pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS2101948096 |
CTSK
|
Health Risk |
Pathogenic |
— |
| RS2101951417 |
CTSK
|
Health Risk |
Pathogenic |
— |
| RS2101951483 |
CTSK
|
Health Risk |
Likely pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS2101951545 |
CTSK
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyknodysostosis, Pyknodysostosis |
| RS2101951549 |
SPTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2101951608 |
CTSK
|
Health Risk |
Pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS2101951629 |
CTSK
|
Health Risk |
Likely pathogenic |
— |
| RS2101951641 |
CTSK
|
Health Risk |
Pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS2101951646 |
CTSK
|
Health Risk |
Pathogenic |
— |
| RS2101951671 |
CTSK
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS2101951682 |
CTSK
|
Health Risk |
Pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS2101953129 |
CTSK
|
Health Risk |
Pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS2101953162 |
CTSK
|
Health Risk |
Pathogenic |
— |
| RS2101953352 |
CTSK
|
Health Risk |
Pathogenic |
— |
| RS2101953359 |
CTSK
|
Health Risk |
Likely pathogenic |
— |
| RS2101953595 |
CTSK
|
Health Risk |
Likely pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS2101954034 |
CTSK
|
Health Risk |
Pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS2101957676 |
SPTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2101958311 |
SPTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2101962817 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 2, Stickler syndrome type 2 |
| RS2101965598 |
PMVK
|
Health Risk |
Likely pathogenic |
Linear porokeratosis, Linear porokeratosis |
| RS2101975422 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS2101982402 |
HJV
|
Health Risk |
Pathogenic |
— |
| RS2101982519 |
HJV
|
Health Risk |
Pathogenic |
— |
| RS2101984042 |
HJV
|
Health Risk |
Likely pathogenic |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS2101984222 |
HJV
|
Health Risk |
Likely pathogenic |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS2101984266 |
HJV
|
Health Risk |
Pathogenic |
— |
| RS2101984343 |
HJV
|
Health Risk |
Pathogenic |
— |
| RS2101984593 |
HJV
|
Health Risk |
Pathogenic |
— |
| RS2101984604 |
HJV
|
Health Risk |
Pathogenic |
— |
| RS2101984855 |
HJV
|
Health Risk |
Pathogenic |
— |
| RS2101984887 |
HJV
|
Health Risk |
Pathogenic |
— |
| RS2101985522 |
ATP1A2
|
Health Risk |
Likely pathogenic |
Familial hemiplegic migraine, Familial hemiplegic migraine |
| RS2101985658 |
HJV
|
Health Risk |
Likely pathogenic |
— |
| RS2101986321 |
HJV
|
Health Risk |
Likely pathogenic |
— |
| RS2101986549 |
HJV
|
Health Risk |
Pathogenic |
— |
| RS2101986552 |
HJV
|
Health Risk |
Likely pathogenic |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS2101986777 |
ATP1A2
|
Health Risk |
Pathogenic |
Familial hemiplegic migraine, Familial hemiplegic migraine |
| RS2101988410 |
ATP1A2
|
Health Risk |
Pathogenic |
Familial hemiplegic migraine, Familial hemiplegic migraine |
| RS2101988461 |
ATP1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemiplegic migraine, See cases |
| RS2101989829 |
ATP1A2
|
Health Risk |
Pathogenic |
Familial hemiplegic migraine, Inborn genetic diseases |
| RS2101995228 |
KCND3
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 19/22, Spinocerebellar ataxia type 19/22 |
| RS2101995423 |
ATP1A2
|
Health Risk |
Pathogenic |
Spastic ataxia, Spastic ataxia |
| RS2101995474 |
ATP1A2
|
Health Risk |
Likely pathogenic |
— |
| RS2101995480 |
ATP1A2
|
Health Risk |
Likely pathogenic |
Alternating hemiplegia of childhood 1, Alternating hemiplegia of childhood 1 |
| RS2101995530 |
KCND3
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 19/22, Spinocerebellar ataxia type 19/22 |
| RS2101995572 |
KCND3
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 19/22, Spinocerebellar ataxia type 19/22 |
| RS2101995847 |
ATP1A2
|
Health Risk |
Likely pathogenic |
Familial hemiplegic migraine, Familial hemiplegic migraine |
| RS2101995864 |
ATP1A2
|
Health Risk |
Likely pathogenic |
Familial hemiplegic migraine, Migraine |
| RS2101996488 |
ATP1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Migraine, familial hemiplegic |
| RS2101997230 |
KCND3
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 19/22, Cardiovascular phenotype |
| RS2102000044 |
ATP1A2
|
Health Risk |
Likely pathogenic |
— |
| RS2102003035 |
NPHP4
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2102011470 |
TNR
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, nonprogressive |
| RS2102020754 |
PRG4
|
Health Risk |
Likely pathogenic |
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, Camptodactyly-arthropathy-coxa vara-pericarditis syndrome |
| RS2102025845 |
PRG4
|
Health Risk |
Pathogenic |
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, Camptodactyly-arthropathy-coxa vara-pericarditis syndrome |
| RS2102028973 |
PRG4
|
Health Risk |
Pathogenic |
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, Camptodactyly-arthropathy-coxa vara-pericarditis syndrome |
| RS2102030658 |
NDUFS2
|
Health Risk |
Pathogenic |
— |
| RS2102031816 |
PRG4
|
Health Risk |
Pathogenic |
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, Camptodactyly-arthropathy-coxa vara-pericarditis syndrome |
| RS2102034857 |
TNR
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, nonprogressive |
| RS2102038469 |
CDC73
|
Health Risk |
Likely pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS2102038475 |
CDC73
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2102038969 |
PRG4
|
Health Risk |
Pathogenic |
— |
| RS2102057068 |
NDUFS2
|
Health Risk |
Likely pathogenic |
— |
| RS2102058252 |
CDC73
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2102058495 |
CDC73
|
Health Risk |
Likely pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS2102061867 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS2102061886 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS2102061912 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS2102063243 |
CACNA1E
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 69 |
| RS2102065180 |
RFX5
|
Health Risk |
Likely pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2102068023 |
RFX5
|
Health Risk |
Pathogenic |
MHC class II deficiency 3, MHC class II deficiency |
| RS2102068802 |
EDEM3
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation, type 2v |
| RS2102081225 |
EDEM3
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation, type 2v |
| RS2102081233 |
EDEM3
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation, type 2v |
| RS2102089507 |
EDEM3
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation, type 2v |
| RS2102093642 |
EDEM3
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation, type 2v |
| RS2102095661 |
HMCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2102105455 |
TAF13
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 60 |
| RS2102125471 |
CADM3
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, axonal |
| RS2102127825 |
DDR2
|
Health Risk |
Pathogenic |
— |
| RS2102132473 |
CACNA1S
|
Health Risk |
Pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS2102135193 |
DDR2
|
Health Risk |
Likely pathogenic |
— |
| RS2102135828 |
CACNA1S
|
Health Risk |
Pathogenic |
Congenital myopathy 18, Centronuclear myopathy |
| RS2102135936 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS2102140073 |
NPHP4
|
Health Risk |
Pathogenic |
— |
| RS2102142398 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS2102144416 |
CACNA1S
|
Health Risk |
Pathogenic/Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS2102145038 |
POGZ
|
Health Risk |
Likely pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS2102145228 |
POGZ
|
Health Risk |
Pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS2102145521 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS2102146729 |
POGZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS2102146999 |
NEXN
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1CC, Hypertrophic cardiomyopathy 20 |
| RS2102147153 |
POGZ
|
Health Risk |
Pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Inborn genetic diseases |
| RS2102147202 |
NEXN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1CC, Hypertrophic cardiomyopathy 20 |
| RS2102149671 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS2102150015 |
POGZ
|
Health Risk |
Pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS2102150755 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS2102151799 |
CACNA1S
|
Health Risk |
Pathogenic |
Hypokalemic periodic paralysis, type 1 |